SynthesisFrontiers in oncology2025
Progress and current trends in prediction models for the occurrence and prognosis of cancer and cancer-related complications: a bibliometric and visualization analysis.
Synthesis in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Prediction models, which estimate disease or outcome probabilities, are widely used in cancer research. This study aims to identify hotspots and future directions of cancer-related prediction models using bibliometrics. Methods: A comprehensive literature search was conducted in the Science Citation Index Expanded (SCIE) from the Web of Science Core Collection (WoSCC) up to November 15, 2024, focusing on cancer-related prediction models research. Co-occurrence analyses of countries, institutions, authors, journals, and keywords were conducted using VOSviewer 1.6.20. Additionally, keyword clustering, timeline visualization, and burst term analysis were performed with CiteSpace 6.3. Results: A total of 1,661 records were retrieved from the SCIE. After deduplication and eligibility screening, 1,556 publications were included in the analysis. The bibliometric analysis revealed a consistent annual increase in cancer-related prediction model research, with China and the United States emerging as the leading contributors. The United States, England, and the Netherlands had the strongest collaborative networks. The most frequent keywords, excluding "prediction model" and "predictive model", included nomogram (frequency=192), survival (191), risk (121), prognosis (112), breast cancer (103), carcinoma (93), validation (87), surgery (85), diagnosis (83), chemotherapy (80), and machine learning (77). Besides, the timeline view analysis indicated that the "#7 machine learning" cluster was experiencing vigorous growth. Conclusion: Cancer-related prediction models are rapidly advancing, especially in prognostic models. Emerging modeling techniques, such as neural networks and deep learning algorithms, are likely to play a pivotal role in current and future cancer-related prediction model research. Systematic reviews of cancer-related predictive models, which could help clinicians select the optimal model for specific clinical conditions may emerge as potential research directions in this field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.